Skip to main content
Many Rare Disease Patients Would Not Have Treatments Available to Them without an Adequate Supply of Human Plasma
Many Rare Disease Patients Would Not Have Treatments Available to Them without an Adequate Supply of Human Plasma, and patients call plasma donors "heroes" for their lifesaving contributions.
  • More than 1,000 plasma donations may be needed to treat one adult patient with a rare disease for a year
  • During International Plasma Awareness Week, plasma donors are recognized by patients and the industry as “heroes”
  • BioBlog – read patients’ powerful perspectives about donors on CSL Behring’s official blog site

Plasma-derived therapies are crucial for the health and well-being of patients with rare and serious medical disorders, and an appropriate supply of products is absolutely essential and depends on a sufficient supply of collected plasma.

It can take more than 1,000 plasma donations to treat one adult patient for a year. For this reason, during International Plasma Awareness Week (October 9-15), CSL Behring and CSL Plasma join the Plasma Protein Therapeutics Association and rest of the industry in recognizing plasma donors for their lifesaving donations.

Without plasma donations and the biotherapies that are made from them, patients like Barb Roberts and Jennifer Gardner, each of whom has an immune deficiency, would not be able to lead full, healthy lives. Their powerful perspectives are featured in the latest post on BioBlog.

About CSL Behring

CSL Behring is a global biotherapeutics leader, which is driven by its promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL), headquartered in Melbourne, Australia, employs more than 16,000 people with operations in more than 60 countries.

For more information visit and follow us on

About CSL Plasma

CSL Plasma, headquartered in Boca Raton, Fla., upholds a tradition of innovation and excellence. As a leader in plasma collection, we are committed to excellence and innovation in everything we do. Our work ensures that tens of thousands of people are able to live normal, healthy lives. We are committed to our work because people's lives depend on us. CSL Plasma is a division of CSL Behring. For more information about CSL Plasma, including eligibility requirements, please go to


Media Contact

Name: Chris Florentz, CSL Behring
Office: 610-878-4316
Mobile: 484-238-8509

Name: Robert Mitchell, CSL Plasma
Office: 561-912-3010
Mobile: 561-245-1861

Get our latest news releases in your inbox
* Required Fields